IdentificationGeneric Name(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDEDrugBank Accession NumberDB07026BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE (DB07026)× CloseWeightAverage: 383.3978 Monoisotopic: 383.148120797 Chemical FormulaC20H21N3O5SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUMacrophage metalloelastaseNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond.KingdomOrganic compoundsSuper ClassBenzenoidsClassBenzene and substituted derivativesSub ClassBiphenyls and derivativesDirect ParentBiphenyls and derivativesAlternative ParentsMorpholine carboxylic acids and derivatives / 1,4-oxazepines / 1,3-dioxolanes / Secondary carboxylic acid amides / Organic carbonic acids and derivatives / Oxacyclic compounds / Azacyclic compounds / Acetals / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds


 show 3 moreSubstituentsAcetal / Aromatic heteropolycyclic compound / Azacycle / Biphenyl / Carbonic acid derivative / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Hydrocarbon derivative / Meta-dioxolane / Morpholine / Morpholine-4-carboxylic acid or derivatives / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organoheterocyclic compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Oxacycle / Oxazinane / Para-oxazepine / Secondary carboxylic acid amide


 show 13 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyPPLDARNGJSQINK-OKZBNKHCSA-NInChIInChI=1S/C20H21N3O5/c24-19(18-16-11-23(20(25)22-26)12-17(27-16)28-18)21-10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9,16-18,26H,10-12H2,(H,21,24)(H,22,25)/t16-,17-,18+/m0/s1IUPAC Name(1S,5S,7R)-N7-({[1,1'-biphenyl]-4-yl}methyl)-N3-hydroxy-6,8-dioxa-3-azabicyclo[3.2.1]octane-3,7-dicarboxamideSMILES[H][C@]12CN(C[C@]([H])(O1)[C@@]([H])(O2)C(=O)NCC1=CC=C(C=C1)C1=CC=CC=C1)C(=O)NOReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound11987860PubChem Substance99443497ChemSpider10160333BindingDB29018ZINCZINC000053683784PDBe Ligand37APDB Entries2hu6Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.458 mg/mLALOGPSlogP1.34ALOGPSlogP1.51ChemaxonlogS-2.9ALOGPSpKa (Strongest Acidic)10.04ChemaxonpKa (Strongest Basic)-4.1ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area100.13 Å2ChemaxonRotatable Bond Count4ChemaxonRefractivity99.56 m3·mol-1ChemaxonPolarizability39.77 Å3ChemaxonNumber of Rings4ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9709Blood Brain Barrier+0.8417Caco-2 permeable-0.6685P-glycoprotein substrateNon-substrate0.5548P-glycoprotein inhibitor INon-inhibitor0.7543P-glycoprotein inhibitor IINon-inhibitor0.9602Renal organic cation transporterNon-inhibitor0.8647CYP450 2C9 substrateNon-substrate0.8304CYP450 2D6 substrateNon-substrate0.8136CYP450 3A4 substrateNon-substrate0.5622CYP450 1A2 substrateNon-inhibitor0.8043CYP450 2C9 inhibitorNon-inhibitor0.748CYP450 2D6 inhibitorNon-inhibitor0.8618CYP450 2C19 inhibitorNon-inhibitor0.6286CYP450 3A4 inhibitorNon-inhibitor0.7907CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8539Ames testAMES toxic0.5515CarcinogenicityNon-carcinogens0.7753BiodegradationNot ready biodegradable0.5076Rat acute toxicity2.5093 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9103hERG inhibition (predictor II)Non-inhibitor0.6299  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Macrophage metalloelastaseKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionZinc ion bindingSpecific FunctionMay be involved in tissue injury and remodeling. Has significant elastolytic activity. Can accept large and small amino acids at the P1' site, but has a preference for leucine. Aromatic or hydropho...Gene NameMMP12Uniprot IDP39900Uniprot NameMacrophage metalloelastaseMolecular Weight54001.175 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:18 / Updated at June 12, 2020 16:52 